Trifecta Capital Advisors’s CVS Health CVS Stock Holding History

Trifecta Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.86K	Buy	+18	New	+$1.61K	﹤0.01%	310
2024 Q2	–	Sell	-1,500	Closed	-$120K	–	422
2024 Q1	$120K	Sell	1,500 -11	-0.7%	-$840	0.03%	104
2023 Q4	$119K	Sell	1,511 -57	-4%	-$4.06K	0.03%	98
2023 Q3	$109K	Buy	1,568 +25	+2%	+$1.77K	0.04%	99
2023 Q2	$107K	Buy	1,543 +11	+0.7%	+$783	0.03%	105
2023 Q1	$114K	Buy	1,532 +1,500	+4,688%	+$126K	0.04%	104
2022 Q4	$2.98K	Buy	+32	New	+$3.09K	﹤0.01%	259

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Trifecta Capital Advisors's CVS Position: Q2 2026 in Review

Trifecta Capital Advisors opened a new position in CVS Health (CVS) in Q2 2026: 18 shares worth $1.86K. The stake represents ﹤0.01% of the portfolio and ranks #310 among its holdings. This is a return to the name: Trifecta Capital Advisors previously reported a position in CVS as recently as Q1 2024.

Trifecta Capital Advisors first reported a position in CVS in Q4 2022 and has held it in 7 quarters since. The position peaked at $120K in Q1 2024. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Trifecta Capital Advisors held 18 shares of CVS Health worth $1.86K as of Q2 2026.
CVS Health was a new Trifecta Capital Advisors position in Q2 2026.
CVS Health made up ﹤0.01% of Trifecta Capital Advisors's portfolio in Q2 2026, its #310 holding.
Trifecta Capital Advisors first reported a position in CVS Health in Q4 2022 and has held it in 7 quarters since.
Trifecta Capital Advisors's CVS Health position peaked at $120K in Q1 2024.
2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Trifecta Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.